| RS1334947797 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS1334949550 |
NAGLU
|
Health Risk |
Likely pathogenic |
— |
| RS1334951339 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1334955221 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1334961999 |
MKKS
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS1334966870 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1334969117 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1334973313 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1334974448 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1334975553 |
POLG2
|
Health Risk |
Pathogenic |
— |
| RS1334986893 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS1335019385 |
FUCA1
|
Health Risk |
Likely pathogenic |
Fucosidosis, Fucosidosis |
| RS1335022 |
GRIK2
|
Health Risk |
association |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS1335028282 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1335036396 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS1335050702 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS1335054266 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS1335055740 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1335060938 |
RNF13
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 73 |
| RS1335063379 |
THOC6
|
Health Risk |
Likely pathogenic |
— |
| RS1335076773 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 6, Type 2 diabetes mellitus |
| RS1335078305 |
TMPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 2, Loeys-Dietz syndrome 2 |
| RS1335120510 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1335126943 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Gnathodiaphyseal dysplasia |
| RS1335130331 |
DIAPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome, Autosomal dominant nonsyndromic hearing loss 1 |
| RS1335137805 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1335145792 |
MECR
|
Health Risk |
Pathogenic |
— |
| RS1335168882 |
SERPING1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS1335171880 |
OBSL1
|
Health Risk |
Pathogenic |
3M syndrome 2, 3M syndrome 2 |
| RS1335196025 |
TRDN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1335209785 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1335215379 |
RNF216
|
Health Risk |
Pathogenic |
Cerebellar ataxia-hypogonadism syndrome, Cerebellar ataxia-hypogonadism syndrome |
| RS1335267315 |
ASPA
|
Health Risk |
Likely pathogenic |
Spongy degeneration of central nervous system, Spongy degeneration of central nervous system |
| RS1335300113 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1335307553 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1335308693 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1335324642 |
SLC4A11
|
Health Risk |
Pathogenic |
Corneal dystrophy-perceptive deafness syndrome, Corneal dystrophy-perceptive deafness syndrome |
| RS1335327546 |
ZMYND10
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1335330614 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1335342521 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, VPS13B-related disorder |
| RS1335346154 |
VPS53
|
Health Risk |
Likely pathogenic |
— |
| RS1335347265 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1335352747 |
SLC38A8
|
Health Risk |
Pathogenic |
— |
| RS1335386227 |
DNAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, DNAI1-related disorder |
| RS1335391766 |
IFT122
|
Health Risk |
Conflicting classifications of pathogenicity |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS1335397957 |
PFKM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VII |
| RS1335401362 |
NDUFS7
|
Health Risk |
Likely pathogenic |
— |
| RS1335405008 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1335410914 |
KCNN2
|
Health Risk |
Conflicting classifications of pathogenicity |
KCNN2-related disorder, Dystonia 34 |
| RS1335417539 |
SAMHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 5, Chilblain lupus 2 |
| RS13354324 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1335486327 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS1335486803 |
RSRC1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 70 |
| RS1335539930 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1335556134 |
SLC22A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal carnitine transport defect, Decreased circulating carnitine concentration |
| RS1335558363 |
GNA11
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia 2, Autosomal dominant hypocalcemia 2 |
| RS1335572575 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1335595318 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS1335601482 |
SLC12A3
|
Health Risk |
Pathogenic |
— |
| RS1335606950 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS1335609772 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia |
| RS1335615080 |
CACNA1F
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Congenital stationary night blindness 2A |
| RS1335619157 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1335627502 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS1335664006 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS1335664604 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1335665224 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1335666832 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS1335685844 |
PEX10
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 6A (Zellweger), Peroxisome biogenesis disorder 6B |
| RS1335699710 |
POLR1C
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 3, Treacher Collins syndrome 3 |
| RS1335712213 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1335718486 |
ENG
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1335731178 |
DHTKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2Q, Charcot-Marie-Tooth disease axonal type 2Q |
| RS1335735639 |
TSPAN12
|
Health Risk |
Pathogenic/Likely pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS1335752004 |
AMN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS1335758022 |
ALPL
|
Health Risk |
Likely pathogenic |
Adult hypophosphatasia, Adult hypophosphatasia |
| RS1335776131 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1335777232 |
EBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, MEND syndrome |
| RS1335782281 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1335796595 |
PURA
|
Health Risk |
Conflicting classifications of pathogenicity |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, Inborn genetic diseases |
| RS1335796666 |
CAPN3
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, limb-girdle |
| RS1335804396 |
AP4S1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Spastic paraplegia |
| RS1335874945 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Inborn genetic diseases |
| RS1335880349 |
POLG
|
Health Risk |
Pathogenic |
Progressive sclerosing poliodystrophy, Mitochondrial disease |
| RS1335897946 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Familial cancer of breast |
| RS1335908921 |
LTBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1335922101 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 12, Retinitis pigmentosa 12 |
| RS1335923152 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1335931206 |
ARSL
|
Health Risk |
Pathogenic |
Chondrodysplasia punctata, brachytelephalangic |
| RS1335934380 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS13359508 |
SPARC
|
Health Risk |
Conflicting classifications of pathogenicity |
SPARC-related disorder, Inborn genetic diseases |
| RS1335967859 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1335985800 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1336014764 |
SLCO2A1
|
Health Risk |
Pathogenic |
— |
| RS1336014812 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Adams-Oliver syndrome 5 |
| RS1336022942 |
RPL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS1336033143 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1336053002 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy, Arthrogryposis multiplex congenita 6 |
| RS1336081746 |
CYP27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cholestanol storage disease |
| RS1336100636 |
ACSL5
|
Health Risk |
Pathogenic |
Diarrhea 13, Diarrhea 13 |